Kuo‐Shyan Lin

4.4k total citations
146 papers, 3.5k citations indexed

About

Kuo‐Shyan Lin is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Kuo‐Shyan Lin has authored 146 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Radiology, Nuclear Medicine and Imaging, 59 papers in Oncology and 33 papers in Molecular Biology. Recurrent topics in Kuo‐Shyan Lin's work include Radiopharmaceutical Chemistry and Applications (73 papers), Peptidase Inhibition and Analysis (50 papers) and Medical Imaging Techniques and Applications (31 papers). Kuo‐Shyan Lin is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (73 papers), Peptidase Inhibition and Analysis (50 papers) and Medical Imaging Techniques and Applications (31 papers). Kuo‐Shyan Lin collaborates with scholars based in Canada, United States and Italy. Kuo‐Shyan Lin's co-authors include François Bénard, Joseph Lau, Zhengxing Zhang, Chengcheng Zhang, Jinhe Pan, David M. Perrin, Zhibo Liu, Nadine Colpo, Hsiou‐Ting Kuo and Helen Merkens and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Journal of Clinical Oncology.

In The Last Decade

Kuo‐Shyan Lin

142 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kuo‐Shyan Lin Canada	33	1.7k	1.0k	856	557	506	146	3.5k
Henry F. VanBrocklin United States	35	1.2k 0.7×	636 0.6×	888 1.0×	379 0.7×	234 0.5×	155	3.4k
Ludger M. Dinkelborg Germany	33	1.8k 1.1×	673 0.7×	1.1k 1.2×	414 0.7×	285 0.6×	85	3.8k
Lixin Lang United States	39	1.7k 1.0×	1.3k 1.2×	1.1k 1.3×	616 1.1×	179 0.4×	125	4.3k
Mian M. Alauddin United States	31	1.2k 0.7×	693 0.7×	1.2k 1.4×	407 0.7×	457 0.9×	109	3.4k
Daniëlle J. Vugts Netherlands	40	2.2k 1.3×	1.2k 1.2×	887 1.0×	595 1.1×	574 1.1×	138	4.1k
Olaf Prante Germany	29	1.1k 0.7×	694 0.7×	858 1.0×	495 0.9×	405 0.8×	110	2.5k
Hong Yuan United States	33	917 0.5×	587 0.6×	1.4k 1.7×	477 0.9×	198 0.4×	121	4.4k
Jörg Steinbach Germany	43	2.0k 1.2×	1.7k 1.7×	2.6k 3.0×	834 1.5×	723 1.4×	305	7.4k
Bertrand Kühnast France	31	1.1k 0.6×	576 0.6×	1.2k 1.4×	121 0.2×	355 0.7×	99	3.1k
C. Andrew Boswell United States	29	2.1k 1.3×	1.2k 1.2×	1.2k 1.4×	407 0.7×	189 0.4×	56	3.4k

Countries citing papers authored by Kuo‐Shyan Lin

Since Specialization

Citations

This map shows the geographic impact of Kuo‐Shyan Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kuo‐Shyan Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kuo‐Shyan Lin more than expected).

Fields of papers citing papers by Kuo‐Shyan Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kuo‐Shyan Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kuo‐Shyan Lin. The network helps show where Kuo‐Shyan Lin may publish in the future.

Co-authorship network of co-authors of Kuo‐Shyan Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Kuo‐Shyan Lin. A scholar is included among the top collaborators of Kuo‐Shyan Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kuo‐Shyan Lin. Kuo‐Shyan Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Chao‐Cheng, Lei Wang, Pauline C. Ng, et al.. (2025). A Novel ⁶⁸Ga‐Labeled 2‐Azabicyclo[3.1.0]Hexane‐3‐Carbonitrile‐Based Fibroblast Activation Protein‐Targeted Tracer for Cancer Imaging With Positron Emission Tomography. Journal of Labelled Compounds and Radiopharmaceuticals. 68(3). e4143–e4143.

Liu, Jiaying, et al.. (2025). Exploring percolation of strong network in granular assemblies: the critical roles of particle shape and loading history dependency. Powder Technology. 464. 121282–121282. 1 indexed citations

Merkens, Helen, Hsiou‐Ting Kuo, Pauline C. Ng, et al.. (2024). Development, preclinical evaluation and preliminary dosimetry profiling of SB03178, a first-of-its-kind benzo[h]quinoline-based fibroblast activation protein-α-targeted radiotheranostic for cancer imaging and therapy. European Journal of Medicinal Chemistry. 268. 116238–116238. 5 indexed citations

Merkens, Helen, et al.. (2024). Synthesis and Preclinical Evaluation of Two Novel 68Ga-Labeled Bispecific PSMA/FAP-Targeted Tracers with 2-Nal-Containing PSMA-Targeted Pharmacophore and Pyridine-Based FAP-Targeted Pharmacophore. Molecules. 29(4). 800–800. 2 indexed citations

Zhang, Zhengxing, Hsiou‐Ting Kuo, Helen Merkens, et al.. (2023). Synthesis and Preclinical Evaluation of Three Novel 68Ga-Labeled Bispecific PSMA/FAP-Targeting Tracers for Prostate Cancer Imaging. Molecules. 28(3). 1088–1088. 29 indexed citations

Zhang, Zhengxing, Kuo‐Shyan Lin, A. De Blas, et al.. (2023). Toward ⁶⁸Ga and ⁶⁴Cu Positron Emission Tomography Probes: Is H₂dedpa-N,N′-pram the Missing Link for dedpa Conjugation?. Inorganic Chemistry. 62(50). 20593–20607. 5 indexed citations

Kuo, Hsiou‐Ting, et al.. (2023). Synthesis and Preclinical Evaluation of Novel 68Ga-Labeled (R)-Pyrrolidin-2-yl-boronic Acid-Based PET Tracers for Fibroblast Activation Protein-Targeted Cancer Imaging. Pharmaceuticals. 16(6). 798–798. 5 indexed citations

Kuo, Hsiou‐Ting, et al.. (2023). Novel 68Ga-Labeled Pyridine-Based Fibroblast Activation Protein-Targeted Tracers with High Tumor-to-Background Contrast. Pharmaceuticals. 16(3). 449–449. 7 indexed citations

Kuo, Hsiou‐Ting, Zhengxing Zhang, Chengcheng Zhang, et al.. (2023). Lys-urea-Aad, Lys-urea-Cmc and Lys-urea-Cms as potential pharmacophores for the design of PSMA-targeted radioligands to reduce off-target uptake in kidneys and salivary glands. Theranostics. 13(13). 4559–4573. 5 indexed citations

10.

Kwon, Daniel, Katsuyoshi Takata, Zhengxing Zhang, et al.. (2022). Targeting Refractory Mantle Cell Lymphoma for Imaging and Therapy Using C-X-C Chemokine Receptor Type 4 Radioligands. Clinical Cancer Research. 28(8). 1628–1639. 8 indexed citations

11.

Jaraquemada-Peláez, Marı́a de Guadalupe, Chengcheng Zhang, Jutta Zeisler, et al.. (2022). H₄picoopa─Robust Chelate for ²²⁵Ac/¹¹¹In Theranostics. Bioconjugate Chemistry. 33(10). 1900–1921. 13 indexed citations

12.

Kuo, Hsiou‐Ting, Kuo‐Shyan Lin, Zhengxing Zhang, et al.. (2022). What a difference a methylene makes: replacing Glu with Asp or Aad in the Lys-urea-Glu pharmacophore of PSMA-targeting radioligands to reduce kidney and salivary gland uptake. Theranostics. 12(14). 6179–6188. 21 indexed citations

13.

Wang, Xiaozhu, Marı́a de Guadalupe Jaraquemada-Peláez, Yang Cao, et al.. (2020). H₂CHXhox: Rigid Cyclohexane-Reinforced Nonmacrocyclic Chelating Ligand for [^nat/67/68Ga]Ga³⁺. Inorganic Chemistry. 59(7). 4895–4908. 11 indexed citations

14.

Jaraquemada-Peláez, Marı́a de Guadalupe, Eduardo Aluicio‐Sarduy, Xiaozhu Wang, et al.. (2020). [^nat/44Sc(pypa)]⁻: Thermodynamic Stability, Radiolabeling, and Biodistribution of a Prostate-Specific-Membrane-Antigen-Targeting Conjugate. Inorganic Chemistry. 59(3). 1985–1995. 25 indexed citations

15.

Rousseau, Julie, Marı́a de Guadalupe Jaraquemada-Peláez, Xiaozhu Wang, et al.. (2020). ²²⁵Ac-H₄py4pa for Targeted Alpha Therapy. Bioconjugate Chemistry. 32(7). 1348–1363. 51 indexed citations

16.

Jaraquemada-Peláez, Marı́a de Guadalupe, Hsiou‐Ting Kuo, Helen Merkens, et al.. (2019). Functionally Versatile and Highly Stable Chelator for ¹¹¹In and ¹⁷⁷Lu: Proof-of-Principle Prostate-Specific Membrane Antigen Targeting. Bioconjugate Chemistry. 30(5). 1539–1553. 43 indexed citations

17.

Lepage, Mathieu L., Áron Roxin, Zhengxing Zhang, et al.. (2019). Toward ¹⁸F‐Labeled Theranostics: A Single Agent that Can Be Labeled with ¹⁸F, ⁶⁴Cu, or ¹⁷⁷Lu. ChemBioChem. 21(7). 943–947. 24 indexed citations

18.

Lin, Kuo‐Shyan, Jinhe Pan, Gulisa Turashvili, et al.. (2014). In Vivo Radioimaging of Bradykinin Receptor B1, a Widely Overexpressed Molecule in Human Cancer. Cancer Research. 75(2). 387–393. 51 indexed citations

19.

Lau, Joseph, Jinhe Pan, Zhengxing Zhang, et al.. (2014). Synthesis and evaluation of 18F-labeled tertiary benzenesulfonamides for imaging carbonic anhydrase IX expression in tumours with positron emission tomography. Bioorganic & Medicinal Chemistry Letters. 24(14). 3064–3068. 20 indexed citations

20.

Kil, Kun-Eek, Yu‐Shin Ding, Kuo‐Shyan Lin, et al.. (2007). Synthesis and positron emission tomography studies of carbon-11-labeled imatinib (Gleevec). Nuclear Medicine and Biology. 34(2). 153–163. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact